The anthracycline anticancer drug doxorubicin is an effective and frequently used chemotherapeutic agent for various malignanciesbut it causes acute ventricular dysfunction, and also induces cardiomyopathy and heart failure. One of the mechanisms ofcardiotoxicity of doxorubicin is oxidative stress, which stimulates myocardial remodeling. Matrix metalloproteinases MMP2 andMMP9 play a key role in this process. Despite extensive research, the expression and activity of these enzymes in the doxorubicindamagedheart and the effect of antioxidants on these indicators have not been sufficiently studied. The aim of this work was tostudy the possible cardioprotective effect of the antioxidant drugs corvitin and alpha-ketoglutarate in rats with doxoru...
AbstractLong term survival of childhood cancers is now more than 70%. Anthracyclines, including doxo...
ObjectiveDoxorubicin is a widely used chemotherapy drug, but its application is associated with card...
International audienceThe molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy i...
Background: Doxorubicin can cause cardiotoxicity. Matrix metalloproteinases (MMP) are responsible fo...
Background: Doxorubicin can cause cardiotoxicity. Matrix metalloproteinases (MMP) are responsible fo...
Doxorubicin is a very effective chemotherapeutic agent. However, its use is limited by serious cardi...
Activity of trypsin-like enzymes (ATLE) and gelatinases A and B were studied in the blood plasma and...
The clinical use of anthracyclines in cancer therapy is limited by dose-dependent cardiotoxicity tha...
Aim: Evaluate the influence of doxycycline, an anti-inflammatory and matrix metalloproteinase (MMP) ...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
Doxorubicin is the drug of choice in the treatment of many malignant neoplasms, but its use is limit...
Doxorubicin (DOX; Adricin) is an anthracycline antibiotic, which is an efficient anticancer chemothe...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be caused by free radical-mediated me...
Anthracyclines, such as doxorubicin, are commonly prescribed antineoplastic agents which cause irrev...
The anthracycline anticancer agent doxorubicin has been recognised to induce a dose-dependent cardio...
AbstractLong term survival of childhood cancers is now more than 70%. Anthracyclines, including doxo...
ObjectiveDoxorubicin is a widely used chemotherapy drug, but its application is associated with card...
International audienceThe molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy i...
Background: Doxorubicin can cause cardiotoxicity. Matrix metalloproteinases (MMP) are responsible fo...
Background: Doxorubicin can cause cardiotoxicity. Matrix metalloproteinases (MMP) are responsible fo...
Doxorubicin is a very effective chemotherapeutic agent. However, its use is limited by serious cardi...
Activity of trypsin-like enzymes (ATLE) and gelatinases A and B were studied in the blood plasma and...
The clinical use of anthracyclines in cancer therapy is limited by dose-dependent cardiotoxicity tha...
Aim: Evaluate the influence of doxycycline, an anti-inflammatory and matrix metalloproteinase (MMP) ...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
Doxorubicin is the drug of choice in the treatment of many malignant neoplasms, but its use is limit...
Doxorubicin (DOX; Adricin) is an anthracycline antibiotic, which is an efficient anticancer chemothe...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be caused by free radical-mediated me...
Anthracyclines, such as doxorubicin, are commonly prescribed antineoplastic agents which cause irrev...
The anthracycline anticancer agent doxorubicin has been recognised to induce a dose-dependent cardio...
AbstractLong term survival of childhood cancers is now more than 70%. Anthracyclines, including doxo...
ObjectiveDoxorubicin is a widely used chemotherapy drug, but its application is associated with card...
International audienceThe molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy i...